Quadrant Capital Group LLC Dr Reddys Laboratories LTD Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 172,009 shares of RDY stock, worth $2.18 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
172,009
Previous 32,123
435.47%
Holding current value
$2.18 Million
Previous $2.55 Million
6.43%
% of portfolio
0.19%
Previous 0.18%
Shares
31 transactions
Others Institutions Holding RDY
# of Institutions
264Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$145 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$143 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$127 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$119 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$71.1 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.11B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...